MedPath

The effect of hydroxyzine on bruxism

Phase 2
Conditions
Other somatoform disorders
Bruxism.
Registration Number
IRCT201110203930N13
Lead Sponsor
Vice chancellor for research, Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Children with age range of 3 to 17 years from both gender with bruxism.
Exclusion criteria: Concurrent behavior therapy, psychoanalysis, or relaxation therapy for bruxism; taking benzodiazepines.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual Analogue scale. Timepoint: Pre and post intervention. Method of measurement: Parent report.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath